see and watch :)
After hitting the support of the red trendline, the price has also broken the blue downtrend line and can move towards the specified targets ...
What Is Genopets?
Genopets is the world's first Free-to-Play, Move-to-Earn NFT game on Solana that makes it fun and rewarding to live an active lifestyle. Genopets combines user's step data from their mobile device with blockchain Play-to-Earn economics so players can earn crypto for taking action in real life as they explore the Genoverse evolving and battling...
BNTC Benitec Biopharma Inc is a development-stage biotechnology company which focuses on the development of novel genetic medicines.
The company develops DNA-directed RNA interference based therapeutics.
BlackRock Inc., Renaissance Technologies LLC, Vanguard Group Inc. and Morgan Stanley have stakes in it.
On 2/17/2022 P. Trucchio from HC Wainwright brokerage...
AVROBIO is a clinical-stage gene therapy company to treat rare diseases following a single dose worldwide.
AVRO just released positive data on their Phase 1/2 trial testing the safety and efficacy of AVR-RD-04.
73.42% of the shares are controlled by institutional investors, which gives me a lot of trust in the company.
JPMorgan Chase and BlackRock Inc. have...
BTC Benitec Biopharma is sitting now at a key support from which we can expect a bounce.
We know that earlier this year they had a 7.5mil offering price to the public of $4.25 per share and that Morgan Stanley has a 5.2% stake in the genetic drug company.
Benitec's "proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA...
CRSP CRISPR Therapeutics 52 Week Range 77.42 - 220.20
Now the price is 80.08usd.
Bounced from its last support level.
Barclays has a price target o 148usd for it.
My price target by Q1 2022 is the 100usd resistance.
Looking forward to read your opinion about it.
Hello and welcome to another breakdown of a hot stockpick i've come across with the ticker symbol $QURE. Enjoy and please remember to share!
*this is not investment advice, invest at your own risk*
GTGs US sister (GENE) received some decent attention overnight, GTG should follow thru at some stage.
US Covid test deal released 01/06/21
MC $72M
There are 9B SOI BUT largest holder has acquired 6.6B 73%
Morgan Stanley disclosed in an SEC filing that it had increased its stake in the company by around 5.2%!
Don`t worry, it has still upside potential, despite the 130% increase in the Pre-Market.
Market Cap of only 15.37M
This is a 5X stock, Not trading advice as you know! :)
This was a private call from my trading group and one of my top picks for March.
You...
Technical Analysis
Since early December, we have had over a dozen tails on the purple up-trend arrow drawn in.
The 50sma is now coming into play, as a break below that, could take us another 20% down to the 100sma.
An appropriate level to exit the trade then, would be below the 50sma.
There also horizontal support as we fill the gap.
Important Note:...
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.
NASDAQ:GENE is a great value play here.. TIGHT TIGHT $0.15-$0.20 stop loss while it is sitting on the bottom of the channel it has been trading in... with upside of 15:1 profit to risk ratio. I don't look for the upper channel to hit but the midline is a possibility. The next 24 hours will either hit your stop loss or give you a fat profit. :) GO LONG!
BLCM has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bo...
Click here to read the rest of my analysis on BLCM.
Disclosure: I am long BLCM. This is not a recommendation to buy/sell as I am NOT a financial advisor. Please do your homework before investing.
Was looking at this back in January at ~ $27/share, mentioned it again at $50/share, now might be the last big time to get in on the climb. Shoot your shots boys. NASDAQ:CRSP
